Latest Market News

Capricorn Metals has secured the Mummaloo Project, significantly enlarging its Mt Gibson exploration tenure with promising gold targets just kilometres from existing resources. The $3.5 million deal includes tenements and key physical assets, setting the stage for focused exploration in 2025.

Axiom Properties Limited reported a $518,000 increase in cash reserves for the December quarter, reaching $1.86 million, while extending key debt facilities to support its Mt Barker development and the rapidly expanding ListSure business.

Vintage Energy Ltd has launched a $2.1 million entitlement offer, issuing 417.3 million new shares and free attaching options to fund a production uplift program targeting scale accumulation in its Southern Flank gas fields.

Vintage Energy has launched a $2.1 million entitlement offer to fund a targeted production uplift program at its Odin and Vali gas fields, aiming to significantly increase gas output and cash flow in the near term.

Canterbury Resources reports significant drilling success at its Briggs copper-molybdenum project, with an updated resource estimate and scoping study underway, while exploration at Bismarck yields no economic mineralisation.

Aeeris Ltd reported solid growth in Q2 FY25, driven by increased annual recurring revenue and new contracts across key sectors, while unveiling a promising new technology set to expand its market footprint.

Ramsay Health Care announces key leadership departures and a strategic realignment aimed at strengthening its core Australian hospital business and accelerating transformation under CEO Natalie Davis.

PainChek Ltd reports robust growth with 100,000 contracted licences globally and positive FDA clearance progress, alongside a promising launch of its Infant App targeting a vast new market.

ImpediMed Limited has reported record quarterly revenue and cash receipts for Q2 FY25, alongside significant growth in reimbursement coverage and a robust sales pipeline, signaling strong momentum in its digital health platform business.

Optiscan Imaging Ltd has secured a $1.775 million R&D tax refund for FY24, more than doubling last year’s amount thanks to expanded claims on overseas research. The boost will fund ongoing development of its cutting-edge confocal laser endomicroscopy technology.

BirdDog Technology reports a strategic pivot with four next-generation product launches, a 20% price increase, and a robust cash position, despite a 13% revenue decline in H1 FY25.

Vitrafy Life Sciences reports strong Q2 FY2025 progress, marked by a successful $35 million IPO, promising validation results in animal and human health, and strategic expansion into North America.